Retmarker ^Companies

Retmarker is an organization that develops proprietary Artificial Intelligence technology for screening and monitoring retinal diseases, specifically targeting Diabetic Retinopathy. Their AI technology aims to make the annual screening for Diabetic Retinopathy objective, scalable, and affordable. Retmarker's patented and certified medical device has been successfully used in Diabetic Retinopathy Screening Programs since 2011. Their goal is to provide efficient solutions that empower doctors and specialists to provide the best healthcare to those threatened by Diabetic Retinopathy.